Search


Stifel's Head of Global Equity Capital Markets Seth Rubin shares his take on the state of biotech and the current environment for companies to raise money
He says that markets have taken a pause but he believes they are healthy and not broken, and he is optimistic about the future. Coverage brought to you by
34 minutes ago


Stifel's Head of Global Equity Capital Markets Seth Rubin describes the investor feedback he is hearing about the sector lately, and the fundraising environment for companies
He says that investors are placing fewer, but larger bets on companies lately, and he expects a 'healthy' IPO market in 2026. Coverage brought to you by
Nov 12, 2025






.png)
